Although direct evidence connecting GC–GR activation to tau pathology in FTD is emerging, glucocorticoid signaling is known to promote GSK3β/CDK5-dependent tau phosphorylation in tauopathic models [48], indicating a stress-sensitive mechanism relevant for FTD progression. This evidence concerns the gene MAPT and frontotemporal dementia.